Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Google has gone all in. Instead of merely following OpenAI’s spotlight, Google’s latest announcement of the Gemini 2.5 family ...
Yutori wants to bring AI into the workplace by creating a digital personal assistant that can actually do some work for you ...
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT ...
New accounts filed by Manna Drones Ltd show that the company’s €12.33m pre-tax for 2023 followed a pre-tax loss of €9.9m for ...
President Trump’s latest trade war threat is expected to come into effect this week, but businesses and investors remain ...
LONDON, March 31, 2025 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 Million in its first external funding round. The financing ...
Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate ...
Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.